Health
PharmAust delivers COVID-19 antiviral breakthrough – Business News
ASX-listed pharmaceutical company, PharmAust continues to kick goals in its endeavours to develop antiviral treatment and prevention therapeutics for COVID-19….
ASX-listed pharmaceutical company, PharmAust continues to kick goals in its endeavours to develop antiviral treatment and prevention therapeutics for COVID-19. The company has once again demonstrated that its lead drug candidates monepantel and monepantel sulfone appear to show protection against cell death in non-human primate systems. Human clinical trials are now on the cards with production of the drug suitable for human consumption having already commenced.
Last year the company revealed monepantel’s…
-
Noosa News23 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News23 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
General21 hours agoDairy farmers devastated by floods across parts of New South Wales
-
General24 hours ago‘Aussie Cossack’ Simeon Boikov’s legal fees paid by fund linked to Russian intelligence